https://www.selleckchem.com/pr....oducts/plerixafor.ht
Notably, an approximately 2-fold increased risk of severe hypoglycemia was observed with amiodarone therapy lasting for 180 days (adjusted OR 2.08; 95% CI 1.01-4.3 or at a daily dose greater than 1 defined daily dose (adjusted OR 2.21; 95% CI 1.25-3.91) when concurrently administrating sulfonylureas. A significantly increased risk of hypoglycemia-related composite events was also found with amiodarone concurrently used with sulfonylureas (adjusted OR 1.59; 95% CI 1.13-2.24). Conclusions Concurrent use of amiodarone and sulfonyl
Like
Comment
Share
